RBC Europe’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $340K | Buy |
1,668
+66
| +4% | +$13.5K | 0.02% | 166 |
|
|
2022
Q1 | $337K | Hold |
1,602
| – | – | 0.01% | 180 |
|
|
2021
Q4 | $384K | Sell |
1,602
-862
| -35% | -$207K | 0.02% | 169 |
|
|
2021
Q3 | $697K | Hold |
2,464
| – | – | 0.03% | 171 |
|
|
2021
Q2 | $853K | Sell |
2,464
-40
| -2% | -$13.9K | 0.04% | 155 |
|
|
2021
Q1 | $700K | Buy |
2,504
+357
| +17% | +$99.9K | 0.04% | 164 |
|
|
2020
Q4 | $526K | Buy |
2,147
+216
| +11% | +$52.9K | 0.03% | 174 |
|
|
2020
Q3 | $548K | Sell |
1,931
-20
| -1% | -$5.67K | 0.04% | 164 |
|
|
2020
Q2 | $522K | Sell |
1,951
-461
| -19% | -$123K | 0.04% | 158 |
|
|
2020
Q1 | $763K | Buy |
2,412
+663
| +38% | +$210K | 0.08% | 117 |
|
|
2019
Q4 | $519K | Sell |
1,749
-34
| -2% | -$10.1K | 0.05% | 160 |
|
|
2019
Q3 | $415K | Sell |
1,783
-25
| -1% | -$5.82K | 0.04% | 172 |
|
|
2019
Q2 | $423K | Hold |
1,808
| – | – | 0.04% | 169 |
|
|
2019
Q1 | $427K | Hold |
1,808
| – | – | 0.05% | 160 |
|
|
2018
Q4 | $544K | Hold |
1,808
| – | – | 0.07% | 142 |
|
|
2018
Q3 | $639K | Sell |
1,808
-50
| -3% | -$17.7K | 0.07% | 138 |
|
|
2018
Q2 | $539K | Sell |
1,858
-55
| -3% | -$16K | 0.06% | 151 |
|
|
2018
Q1 | $524K | Sell |
1,913
-111
| -5% | -$30.4K | 0.06% | 150 |
|
|
2017
Q4 | $645K | Buy |
2,024
+63
| +3% | +$20.1K | 0.08% | 135 |
|
|
2017
Q3 | $614K | Buy |
+1,961
| New | +$614K | 0.08% | 137 |
|